Real‐world long‐term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infection

Abstract Background and Aim This study aimed to evaluate the long‐term clinical course of patients achieving a sustained virologic response (SVR) with daclatasvir plus asunaprevir (DCV/ASV) therapy. Methods A total of 911 patients who achieved SVR with DCV/ASV were assessed. To evaluate pretreatment...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hideki Fujii, Hiroyuki Kimura, Chitomi Hasebe, Takehiro Akahane, Takashi Satou, Atsunori Kusakabe, Yuji Kojima, Masahiko Kondo, Hiroyuki Marusawa, Haruhiko Kobashi, Keiji Tsuji, Chikara Ogawa, Yasushi Uchida, Kouji Joko, Akeri Mitsuda, Masayuki Kurosaki, Namiki Izumi
Formato: Artigo
Lenguaje:Inglês
Publicado: Wiley 2022-05-01
Colección:JGH Open
Materias:
asunaprevir
daclatasvir
hepatocellular carcinoma incidence
liver function
Acceso en línea:https://doi.org/10.1002/jgh3.12749
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares